tiprankstipranks
Trending News
More News >
Alnylam Pharmaceuticals (DE:DUL)
FRANKFURT:DUL
Germany Market

Alnylam Pharma (DUL) Technical Analysis

Compare
1 Followers

Summary of all the Indicators

Overall Consensus
Sell
7Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Alnylam Pharmaceuticals’s (DUL) Moving Averages Convergence Divergence (MACD) indicator is -7.95, suggesting Alnylam Pharmaceuticals is a Sell.
Alnylam Pharmaceuticals’s (DUL) 20-Day exponential moving average is 216.27, while Alnylam Pharmaceuticals’s (DUL) share price is €212.8, making it a Sell.
Alnylam Pharmaceuticals’s (DUL) 50-Day exponential moving average is 226.87, while Alnylam Pharmaceuticals’s (DUL) share price is €212.8, making it a Sell.

Alnylam Pharma (DUL) Pivot Points

Apr 26, 2025, 07:51 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
210.90
210.90
210.90
210.90
210.90
210.90
210.90
Fibonacci
210.90
210.90
210.90
210.90
210.90
210.90
210.90
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Alnylam Pharma (DUL) Moving Averages

Apr 26, 2025, 07:51 PM
Period
Simple
Exponential
MA5
207.22Buy
209.13Buy
MA10
207.50Buy
210.15Buy
MA20
219.19Sell
216.27Sell
MA50
229.08Sell
226.87Sell
MA100
235.97Sell
231.44Sell
MA200
238.82Sell
224.27Sell
Alnylam Pharmaceuticals’s (DUL) 10-Day exponential moving average is 210.15, while Alnylam Pharmaceuticals’s (DUL) share price is €212.8, making it a Buy.
Alnylam Pharmaceuticals’s (DUL) 100-Day exponential moving average is 231.44, while Alnylam Pharmaceuticals’s (DUL) share price is €212.8, making it a Sell.
Alnylam Pharmaceuticals’s (DUL) stock price is €212.8 and Alnylam Pharmaceuticals’s (DUL) 50-day simple moving average is 229.08, creating a Sell signal.
Alnylam Pharmaceuticals’s (DUL) stock price is €212.8 and Alnylam Pharmaceuticals’s (DUL) 100-day simple moving average is 235.97, creating a Sell signal.
Alnylam Pharmaceuticals’s (DUL) stock price is €212.8 and Alnylam Pharmaceuticals’s (DUL) 200-day simple moving average is 238.82, creating a Sell signal.

Alnylam Pharma (DUL) Technical Indicators

Apr 26, 2025, 07:51 PM
Name
Value
Implied Action
RSI (14)
46.24
Neutral
STOCH (9,6)
67.57
Neutral
STOCHRSI (14)
32.99
Neutral
MACD (12,26)
-7.95
Sell
ADX (14)
16.27
Buy
Williams %R
-60.28
Buy
CCI (14)
-27.18
Neutral
ATR (14)
7.41
-
Ultimate Oscillator
51.17
Neutral
ROC
-9.60
Sell
Alnylam Pharmaceuticals’s (DUL) Relative Strength Index (RSI) is 46.24, creating a Neutral signal.
Alnylam Pharmaceuticals’s (DUL) Trend Strength Indicator (ADX) is 16.27, creating a Buy signal.
Alnylam Pharmaceuticals’s (DUL) Commodity Channel Index (CCI) is -27.18, creating a Neutral signal.
Alnylam Pharmaceuticals’s (DUL) Price Rate of Change (ROC) is -9.60, creating a Sell signal.

FAQ

Is DUL a Buy, Hold, or Sell?
Based on DUL’s technical indicators, DUL is a Sell.
    What is DUL’s RSI (14)?
    DUL’s RSI (14) is 46.24, which suggests DUL is a Neutral.
      What is DUL’s MACD?
      DUL’s MACD is -7.95, which suggests DUL is a Sell.
        What is DUL’s 5-day moving average?
        DUL’s 5-day moving average is 207.22, which suggests DUL is a Buy.
          What is DUL’s 20-day moving average?
          DUL 20-day moving average is 219.19, which suggests DUL is a Sell.
            What is DUL’s 50-day moving average?
            DUL’s 50-day moving average is 229.08, which suggests DUL is a Sell.
              What is DUL’s 200-day moving average?
              DUL’s 200-day moving average is 238.82, which suggests DUL is a Sell.
                What is DUL’s Williams % R (14)?
                DUL’s Williams % R (14) is -60.28, which suggests DUL is a Buy.
                  What is DUL’s CCI (14)?
                  DUL’s CCI (14) is -27.18, which suggests DUL is a Neutral.
                    What is the share price of Alnylam Pharmaceuticals?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis